These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 26788169

  • 1. Glycogen synthase kinase-3β regulates tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis via the NF-κB pathway in hepatocellular carcinoma.
    Fu K, Pan H, Liu S, Lv J, Wan Z, Li J, Sun Q, Liang J.
    Oncol Lett; 2015 Dec; 10(6):3557-3564. PubMed ID: 26788169
    [Abstract] [Full Text] [Related]

  • 2. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.
    Zhang JS, Herreros-Villanueva M, Koenig A, Deng Z, de Narvajas AA, Gomez TS, Meng X, Bujanda L, Ellenrieder V, Li XK, Kaufmann SH, Billadeau DD.
    Cell Death Dis; 2014 Mar 27; 5(3):e1142. PubMed ID: 24675460
    [Abstract] [Full Text] [Related]

  • 3. Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer.
    Liao X, Zhang L, Thrasher JB, Du J, Li B.
    Mol Cancer Ther; 2003 Nov 27; 2(11):1215-22. PubMed ID: 14617795
    [Abstract] [Full Text] [Related]

  • 4. Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.
    Steinbrecher KA, Wilson W, Cogswell PC, Baldwin AS.
    Mol Cell Biol; 2005 Oct 27; 25(19):8444-55. PubMed ID: 16166627
    [Abstract] [Full Text] [Related]

  • 5. [Expression and clinical significance of nuclear factor κB/B cell lymphoma-2 signal pathway and glycogen synthase kinase 3β in oral squamous cell carcinoma].
    Yuhua Z, Han C, Jiyuan L, Wei Z, Lin Q, Xiufa T.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Feb 27; 33(1):11-5. PubMed ID: 25872291
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
    Wan Z, Pan H, Liu S, Zhu J, Qi W, Fu K, Zhao T, Liang J.
    Oncol Rep; 2015 Mar 27; 33(3):1560-6. PubMed ID: 25607597
    [Abstract] [Full Text] [Related]

  • 7. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
    Deeb D, Jiang H, Gao X, Al-Holou S, Danyluk AL, Dulchavsky SA, Gautam SC.
    J Pharmacol Exp Ther; 2007 May 27; 321(2):616-25. PubMed ID: 17289836
    [Abstract] [Full Text] [Related]

  • 8. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone.
    Ban JO, Kwak DH, Oh JH, Park EJ, Cho MC, Song HS, Song MJ, Han SB, Moon DC, Kang KW, Hong JT.
    Chem Biol Interact; 2010 Oct 06; 188(1):75-85. PubMed ID: 20540935
    [Abstract] [Full Text] [Related]

  • 9. Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells.
    Beurel E, Blivet-Van Eggelpoël MJ, Kornprobst M, Moritz S, Delelo R, Paye F, Housset C, Desbois-Mouthon C.
    Biochem Pharmacol; 2009 Jan 01; 77(1):54-65. PubMed ID: 18938143
    [Abstract] [Full Text] [Related]

  • 10. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.
    Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR.
    Nature; 2000 Jul 06; 406(6791):86-90. PubMed ID: 10894547
    [Abstract] [Full Text] [Related]

  • 11. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
    Ougolkov AV, Fernandez-Zapico ME, Bilim VN, Smyrk TC, Chari ST, Billadeau DD.
    Clin Cancer Res; 2006 Sep 01; 12(17):5074-81. PubMed ID: 16951223
    [Abstract] [Full Text] [Related]

  • 12. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS, Schwabe RF, Qian T, Lemasters JJ, Brenner DA.
    Hepatology; 2002 Dec 01; 36(6):1498-508. PubMed ID: 12447876
    [Abstract] [Full Text] [Related]

  • 13. Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death.
    Thomas RP, Farrow BJ, Kim S, May MJ, Hellmich MR, Evers BM.
    Surgery; 2002 Aug 01; 132(2):127-34. PubMed ID: 12219002
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
    Wang HM, Zhang T, Li Q, Huang JK, Chen RF, Sun XJ.
    Neurochem Int; 2013 Nov 01; 63(5):345-53. PubMed ID: 23871716
    [Abstract] [Full Text] [Related]

  • 15. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
    Kai JI, Huang WC, Tsai CC, Chang WT, Chen CL, Lin CF.
    J Cell Biochem; 2010 Dec 15; 111(6):1522-30. PubMed ID: 20872791
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
    Kim SD, Yang SI, Kim HC, Shin CY, Ko KH.
    Brain Res; 2007 Dec 15; 1186():12-20. PubMed ID: 17996850
    [Abstract] [Full Text] [Related]

  • 17. Sensitization of hepatocellular carcinoma cells to Apo2L/TRAIL by a novel Akt/NF-κB signalling inhibitor.
    Omar HA, Arafa el-SA, Maghrabi IA, Weng JR.
    Basic Clin Pharmacol Toxicol; 2014 Jun 15; 114(6):464-71. PubMed ID: 24401154
    [Abstract] [Full Text] [Related]

  • 18. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
    Li J, Sun RR, Yu ZJ, Liang H, Shen S, Kan Q.
    Cancer Biother Radiopharm; 2015 Oct 15; 30(8):336-41. PubMed ID: 26348206
    [Abstract] [Full Text] [Related]

  • 19. ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-κB dependent cFLIPL expression.
    Liang DY, Huang W, Chang Q, Hou YQ.
    PLoS One; 2018 Oct 15; 13(2):e0191545. PubMed ID: 29444104
    [Abstract] [Full Text] [Related]

  • 20. Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolished by cisplatin.
    Shin EC, Seong YR, Kim CH, Kim H, Ahn YS, Kim K, Kim SJ, Hong SS, Park JH.
    Exp Mol Med; 2002 May 31; 34(2):114-22. PubMed ID: 12085986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.